Framework generates personalized insulin treatment strategies using deep models.
problem Developing optimal personalized treatment strategies for diabetes patients.
method Combines deep generative time series models with decision theory.
result Demonstrated improved personalized insulin treatment strategies for diabetes patients.
System interprets complex treatment effects for personalized policies.
problem Complex, hard-to-understand treatment effect models.
method Scalable, interpretable personalized experimentation system.
result Learned explanations and generated interpretable policies.
New methods optimize personalized treatment assignment in trials with many arms.
problem Poor performance of standard methods in trials with many treatment arms.
method Regularized and clustered joint assignment forest algorithm.
result Gains in predicting arm-wise outcomes and utility gains from personalization.
New method evaluates personalized treatment in critical care, robust to death.
problem Truncation by death in critical care makes traditional DTR evaluation ineffective.
method Principal stratification-based approach, focusing on always-survivor value function, with a semiparametrically efficient, multiply robust estimator.
result Demonstrates robustness and efficiency of the method for personalized treatment optimization.
Personalized models explain TB treatment outcomes considering patient context.
problem Heterogeneity in TB treatment outcomes due to co-morbidities.
method Multi-task learning approach encoding patient context into personalized models.
result Identifies anemia, age of onset, and HIV as influential for treatment efficacy.
AI framework uses multi-omics data to personalize cancer treatment suggestions.
problem Leveraging AI for personalized cancer treatment based on complex patient characteristics.
method Modular machine learning framework trained on diverse multi-omics technologies.
result Superior performance in personalized counterfactual treatment suggestions.
A new algorithm learns optimal personalized treatment plans online with low regret.
problem Learning optimal dynamic treatment regimes in an online setting.
method Developed a novel algorithm balancing exploration and exploitation for rate-optimal regret.
result Guaranteed rate-optimal regret for linear transition and reward models.
Study assesses whether RL algorithm personalizes treatment sequences.
problem Evaluate if RL algorithm truly personalizes treatment sequences.
method Resampling-based methodology to investigate personalization.
result RL algorithm's personalization may be due to stochasticity.
Unified survey of treatment effect heterogeneity and uplift modeling methods.
problem Estimating heterogeneous treatment effects and uplift modeling.
method Unified survey of treatment effect heterogeneity and uplift modeling approaches.
result Unified notations for comparing methods and applications in personalized marketing, medicine, and social studies.
We study the problem of learning to choose from m discrete treatment options (e.g., news item or medical drug) the one with best causal effect for a particular instance (e.g., user or patient) where the training data consists of passive observations of covariates, treatment, and the outcome of the treatment. The standa…
Causal ML predicts treatment outcomes, aiding personalized medicine.
problem Predicting individualized treatment effects for personalized medicine.
method Flexible, data-driven methods using causal inference with clinical trial and real-world data.
result Causal ML allows for estimating individualized treatment effects.
Proposes efficient data acquisition for personalized treatment effects from observational data.
problem Efficiently acquiring outcomes for personalized treatment effects in observational studies.
method Introduces causal, Bayesian acquisition functions to select points with overlapping support.
result Demonstrates improved sample efficiency and accuracy in learning personalized treatment effects.
The personalization of treatment via bio-markers and other risk categories has drawn increasing interest among clinical scientists. Personalized treatment strategies can be learned using data from clinical trials, but such trials are very costly to run. This paper explores the use of active learning techniques to desig…
In many mobile health interventions, treatments should only be delivered in a particular context, for example when a user is currently stressed, walking or sedentary. Even in an optimal context, concerns about user burden can restrict which treatments are sent. To diffuse the treatment delivery over times when a user i…
The causal effect of a treatment can vary from person to person based on their individual characteristics and predispositions. Mining for patterns of individual-level effect differences, a problem known as heterogeneous treatment effect estimation, has many important applications, from precision medicine to recommender…
Paper uses stats to predict treatment choice based on illness probability.
problem Improving treatment decision-making in personalized medicine.
method Statistical decision theory with maximum regret evaluation.
result Estimates illness probability for better treatment choice.
Develops deep jump learning for continuous treatment OPE.
problem Estimating mean outcomes under new treatment rules using historical data from different rules.
method Adaptive deep discretization of continuous treatment space using deep learning and multi-scale change point detection.
result Validated method through theoretical results, simulations, and real application to Warfarin Dosing.
RL algorithms with medical integration improve personalized treatment recommendations.
problem Developing effective personalized treatment strategies for chronic diseases.
method Integrating medical knowledge into RL algorithms for DTR.
result Enhanced treatment recommendations with increased confidence.
The paper clarifies the distinction between CATE and ITE under ignorability assumptions.
problem Confusion between CATE and ITE hinders personalized effect estimation.
method Clarifies the distinction between CATE and ITE under ignorability assumptions.
result CATE and ITE are not necessarily the same under ignorability assumptions.
Estimating the effect of a treatment on a given outcome, conditioned on a vector of covariates, is central in many applications. However, learning the impact of a treatment on a continuous temporal response, when the covariates suffer extensively from measurement error and even the timing of the treatments is uncertain…
Bayesian Supervised Causal Clustering identifies patient subgroups for personalized decision-making.
problem Finding patient subgroups with similar characteristics for personalized decision-making.
method Bayesian Supervised Causal Clustering (BSCC) that identifies homogenous subgroups based on treatment effects.
result BSCC identifies subgroups with similar covariate profiles and treatment effects.
IntelligentPooling improves treatment decisions in mHealth.
problem Optimizing treatment decisions in mobile health with limited data and non-stationary responses.
method Generalized Thompson-Sampling bandit algorithms to IntelligentPooling, addressing differential response, limited data, and non-stationary responses.
result IntelligentPooling achieves 26% lower regret compared to state-of-the-art methods.
In both the fields of computer science and medicine there is very strong interest in developing personalized treatment policies for patients who have variable responses to treatments. In particular, I aim to find an optimal personalized treatment policy which is a non-deterministic function of the patient specific cova…
LI-ITR combines flexible ML with interpretable approximations for personalized treatment rules.
problem Combining flexibility and interpretability in personalized treatment rules.
method Uses variational autoencoders and a mixture of interpretable experts.
result Accurately recovers true local coefficients and optimal treatment strategies.
PDX studies help personalize cancer treatment.
problem Precision medicine in cancer treatment.
method Machine learning methods for estimating optimal ITRs from PDX data.
result Superlearner approach combining multiple ITRs improves personalized treatment recommendations.
Causal ML methods failed to validate their personalized treatment effects in two large trials.
problem Validating causal machine learning methods for personalized treatment effects in precision medicine.
method Assessed 17 mainstream causal heterogeneity ML methods using two large randomized controlled trials.
result None of the ML methods reliably validated their performance, internal or external, showing significant discrepancies between training and test data.
Proposes a method for generating prediction intervals in dose-response models using conformal prediction.
problem Uncertainty quantification in continuous treatments for personalized healthcare decisions.
method Causal dose-response problem framed as covariate shift, using weighted conformal prediction with propensity estimation and kernel functions.
result Demonstrates the significance of covariate shift assumptions for robust prediction intervals.
Tree-based model averaging improves CATE estimation from diverse sites.
problem Limited sample size and privacy concerns prevent accurate personalized treatment effect estimation.
method Tree-based model averaging approach to estimate CATEs from multiple heterogeneous sites.
result Improved accuracy in estimating conditional average treatment effects (CATEs) across sites.
New meta-learners estimate time-varying treatment effects without model assumptions.
problem Estimating treatment effects over time in personalized medicine.
method Model-agnostic meta-learners for weighted pseudo-outcome regressions.
result Comprehensive theoretical analysis and practical insights for choosing meta-learners.
CAPITAL algorithm identifies optimal patient subgroups for better treatment.
problem Identify maximum number of patients benefiting from better treatment.
method Constrained Policy Tree Search (CAPITAL) algorithm to find optimal subgroup selection rule (SSR).
result Maximizes the number of patients with enhanced treatment effects.
Medical practitioners use survival models to explore and understand the relationships between patients' covariates (e.g. clinical and genetic features) and the effectiveness of various treatment options. Standard survival models like the linear Cox proportional hazards model require extensive feature engineering or pri…
Estimates personalized treatment response curves using covariates.
problem Flexible estimation of personalized treatment response curves.
method Sieve based nonparametric estimator of smoothed regimen-response curve function.
result Asymptotic linearity and undersmoothing criteria for efficient estimation.
Develops a method to estimate personalized treatment regimes from summary statistics.
problem Estimating optimal treatment regimes for a target population when individual-level data is unavailable.
method A weighting framework that tailors a treatment regime for the target population using summary statistics.
result Consistent and asymptotically normal estimator for optimal treatment regimes.
Personalized medicine aims at identifying best treatments for a patient with given characteristics. It has been shown in the literature that these methods can lead to great improvements in medicine compared to traditional methods prescribing the same treatment to all patients. Subgroup identification is a branch of per…
Estimates personalized policies robust to shifts in target populations.
problem Estimating policies that perform well in diverse target populations.
method Develops methods for estimating robust policies considering shifts in outcomes and characteristics.
result Welfare-maximizing policies are robust to certain shifts in potential outcomes.
SAFER improves personalized treatment recommendations for dynamic clinical contexts.
problem Personalized treatment optimization in evolving clinical contexts with safety concerns.
method Integrates structured EHR and clinical notes, uses conformal prediction for safe recommendations.
result SAFER outperforms state-of-the-art baselines in recommendation metrics and mortality rates.
PNNs improve personalized healthcare policies using mixed integer programming.
problem Learning treatment policies for patients with limited data.
method Prescriptive networks (PNNs) trained with mixed integer programming.
result PNNs outperform existing methods in reducing peak blood pressure.
Paper tackles gene mutation prediction for HCC using multi-instance multi-label learning.
problem Gene mutation prediction in hepatocellular carcinoma for personalized treatments.
method Multi-instance multi-label learning with oversampling for data imbalance.
result Proposed approach shows superiority in gene mutation prediction.
Aims to improve personalized treatment decisions through Bayesian experimental design.
problem Evaluating and improving personalized treatment decisions in contexts like customer service.
method Model-agnostic Bayesian Experimental Design to efficiently gather data and avoid highly sub-optimal treatments.
result Our method achieves superior performance in evaluating and improving treatment decisions compared to traditional approaches.
The paper estimates personalized treatment effects in medical settings with competing risks.
problem Estimating treatment effectiveness for specific events in the presence of alternative event types.
method Meta-learners combining Cox regression or random survival forests for risk modeling and elastic net regression or random forests for direct CATE modeling.
result Compared meta-learners in multiple simulation settings, providing practical guidance for model selection.
We study the problem of estimating the continuous response over time to interventions using observational time series---a retrospective dataset where the policy by which the data are generated is unknown to the learner. We are motivated by applications where response varies by individuals and therefore, estimating resp…
Proposes a deep spectral Q-learning for mobile health data.
problem Personalized treatment assignment for patients with time-varying covariates.
method Integrates PCA with deep Q-learning for mixed frequency data.
result Mean return converges to optimal under estimated optimal policy.
Estimates price sensitivity from transaction data using a novel odds ratio method.
problem Estimate price sensitivity from transaction-level data with partially observed treatment assignments.
method Recursive partitioning procedure with adversarial imputation for robust estimation.
result Validated on synthetic data and applied to three case studies, demonstrating heterogeneity in treatment effects.
PO-Flow models potential and counterfactual outcomes for personalized treatment decisions.
problem Predicting individualized treatment effects from observational data.
method Continuous normalizing flow (CNF) framework for causal inference.
result Unified approach to potential outcome prediction, treatment effect estimation, and counterfactual prediction.
Develops methods to learn optimal treatment regimes using causal tree methods.
problem Lack of methods for estimating treatment effects and handling complex patient data.
method Causal tree and causal forest methods for estimating heterogeneous treatment effects.
result Outperforms state-of-the-art baselines in cumulative regret and percentage of optimal decisions.
FOCaL meta-learner estimates functional treatment effects robustly.
problem Estimating heterogeneous treatment effects from functional outcomes.
method Doubly robust meta-learner FOCaL integrating functional regression.
result Direct and robust estimation of F-CATE.
New method for personalized pricing using invalid instrumental variables.
problem Personalized pricing under endogeneity with limited standard methods.
method PRINT method for continuous treatment, solving conditional moment restrictions.
result Established optimal pricing strategy under endogeneity with invalid instrumental variables.
Framework improves health by planning actionable treatment processes.
problem Developing objective treatment processes in clinical settings.
method Surrogate Bayesian model combined with ML for personalized health improvement.
result Computed treatment processes are actionable and consistent with clinical knowledge.